Compass therapeutics provides corporate update

Boston, jan. 05, 2024 (globe newswire) -- compass therapeutics, inc. (nasdaq: cmpx), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today reported a business update.
CMPX Ratings Summary
CMPX Quant Ranking